Affimed Financial Statements (AFMD)

Affimedsmart-lab.ru   FY2019 FY2020 FY2021 FY2022 FY2023   LTM ?
Report date 28.04.2020 15.04.2021 31.03.2022 23.03.2023 28.03.2024   30.09.2024
Currency EUR EUR EUR EUR EUR   EUR
Financial report URL  
Revenue, ? 21 391 000 28 360 000 40 366 000 41 353 000 8 275 000   877 000
Operating Income, -32 376 000 -34 718 000 -64 030 000 -88 119 000 -106 661 000   -70 206 000
EBITDA, ? -30 972 000 -40 231 161 -55 421 787 -81 473 000 -102 380 000   -65 187 000
Net profit, ? -32 365 000 -41 366 000 -57 523 000 -86 004 000 -105 938 000   -69 970 000
OCF, ? -29 056 000 -19 400 000 -86 591 000 -104 892 000 -110 269 000   -76 904 000
CAPEX, ? 1 474 000 440 000 3 850 000 696 000 3 729 000   534 000
FCF, ? -30 530 000 -19 840 000 -90 441 000 -105 588 000 -113 998 000   -77 438 000
Dividend payout, 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, 54 037 000 63 704 000 105 706 000 130 889 000 114 936 000   74 616 000
Cost of production, 0.000 0.000 0.000 0.000 0.000   0.000
R&D, 43 791 000 49 989 000 81 488 000 98 814 000 94 958 000   55 910 000
Interest expenses, 483 000 95 000 712 000 1 630 000 1 806 000   1 358 000
Assets, 112 359 000 175 725 000 225 135 000 200 512 000 97 157 000   39 959 000
Net Assets, ? 38 667 000 71 993 000 135 951 000 152 915 000 57 807 000   17 195 000
Debt, 3 187 000 1 297 000 18 691 000 18 189 000 19 351 000   12 889 000
Cash, 104 136 000 146 854 000 197 630 000 190 286 000 72 898 000   24 940 000
Net debt, -100 949 000 -145 557 000 -178 939 000 -172 097 000 -53 547 000   -12 051 000
Ordinary share price, rub 27.4 58.2 55.2   0.182
Number of ordinary shares, mln 6 424 240 8 347 156 11 950 238 14 236 229 14 939 916   16 100 185
Market cap, 176 024 176 485 804 479 659 653 138 0.00 0.00   2 922 184
EV, ? 75 075 176 340 247 479 480 714 138 -172 097 000 -53 547 000   -9 128 816
Book value, 38 530 000 70 275 000 134 344 000 152 857 000 57 782 000   17 180 000
EPS, rub ? -5.04 -4.96 -4.81 -6.04 -7.09   -4.35
FCF/share, rub -4.75 -2.38 -7.57 -7.42 -7.63   -4.81
BV/share, rub 6.00 8.42 11.2 10.7 3.87   1.07
EBITDA margin, % ? -144.8% -141.9% -137.3% -197.0% -1 237%   -7 433%
Net margin, % ? -151.3% -145.9% -142.5% -208.0% -1 280%   -7 978%
FCF yield, % ? -17.3% -4.08% -13.7%   -2 650%
ROE, % ? -83.7% -57.5% -42.3% -56.2% -183.3%   -406.9%
ROA, % ? -28.8% -23.5% -25.6% -42.9% -109.0%   -175.1%
P/E ? -5.44 -11.7 -11.5 0.00 0.00   -0.04
P/FCF -5.77 -24.5 -7.29 0.00 0.00   -0.04
P/S ? 8.23 17.1 16.3 0.00 0.00   3.33
P/BV ? 4.57 6.91 4.91 0.00 0.00   0.17
EV/EBITDA ? -2.42 -8.46 -8.67 2.11 0.52   0.14
Debt/EBITDA 3.26 3.62 3.23 2.11 0.52   0.18
R&D/CAPEX, % 2 971% 11 361% 2 117% 14 197% 2 546%   10 470%
CAPEX/Revenue, % 6.89% 1.55% 9.54% 1.68% 45.1%   60.9%
Affimed shareholders